Skip to main content
Erschienen in: Breast Cancer 6/2019

15.04.2019 | Original Article

Reproductive history and breast cancer survival: a prospective patient cohort study in Japan

verfasst von: Yuko Minami, Yoshikazu Nishino, Masaaki Kawai, Hiroshi Tada, Seiki Kanemura, Minoru Miyashita, Takanori Ishida, Yoichiro Kakugawa

Erschienen in: Breast Cancer | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Reproductive factors may influence breast cancer progression and patient survival; however, evidence has been limited.

Methods

The associations of reproductive factors with tumor characteristics and patient survival were analyzed among 1468 breast cancer patients diagnosed during 1997–2013 at a single institute in Japan. The patients were followed until 2016. During a median follow-up period of 8.6 years, 272 all-cause and 199 breast cancer deaths were documented.

Results

In case–case comparisons, later age at menarche was inversely associated with advanced tumors. Nulliparous patients tended to have receptor-positive [estrogen receptor (ER)+ or progesterone receptor (PR)+] tumors. Conversely, the Cox proportional-hazards model including adjustment for tumor characteristics revealed U-shaped relationship between parity number and the risk of all-cause death among the patients overall [hazard ratio (HR) = 2.10 for nulliparous, 1.28 for 2, and 1.50 for ≥ 3 vs. one child]. According to hormone receptor, later age at menarche and later age at last birth were positively associated with the risk of all-cause death among patients with ER– and PR– cancer (menarche, HR = 2.18 for ≥ 15 vs. ≤ 12 years, ptrend = 0.03; last birth, HR = 3.10 for ≥ 35 vs. ≤ 29 years, ptrend = 0.01). A shorter time since last birth was associated with the risk of death among receptor-positive patients (HR = 5.72 for ≤ 4 vs. ≥ 10 years, ptrend = 0.004).

Conclusion

The results indicate that the timing of menarche and parity have significant effects on patient survival, providing clues for understanding the association between women’s life course and breast cancer outcome.
Literatur
1.
Zurück zum Zitat Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev. 1993;15:36–47.CrossRef Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev. 1993;15:36–47.CrossRef
2.
Zurück zum Zitat Kawai M, Minami Y, Kuriyama S, Kakizaki M, Kakugawa Y, Nishino Y, Ishida T, Fukao A, Tsuji I, Ohuchi N. Reproductive factors, exogenous female hormone use and breast cancer risk in Japanese: the Miyagi Cohort Study. Cancer Causes Control. 2010;21:135–45.CrossRef Kawai M, Minami Y, Kuriyama S, Kakizaki M, Kakugawa Y, Nishino Y, Ishida T, Fukao A, Tsuji I, Ohuchi N. Reproductive factors, exogenous female hormone use and breast cancer risk in Japanese: the Miyagi Cohort Study. Cancer Causes Control. 2010;21:135–45.CrossRef
3.
Zurück zum Zitat Kyogoku S, Hirohata T, Takeshita S, Nomura Y, Shigematsu T, Horie A. Survival of breast-cancer patients and body size indicators. Int J Cancer. 1990;46:824–31.CrossRef Kyogoku S, Hirohata T, Takeshita S, Nomura Y, Shigematsu T, Horie A. Survival of breast-cancer patients and body size indicators. Int J Cancer. 1990;46:824–31.CrossRef
4.
Zurück zum Zitat Nagatsuma AK, Shimizu C, Takahashi F, Tsuda H, Saji S, Hojo T, Sugano K, Takeuchi M, Fujii H, Fujiwara Y. Impact of recent parity on histopathological tumor features and breast cancer outcome in premenopausal Japanese women. Breast Cancer Res Treat. 2013;138:941–50.CrossRef Nagatsuma AK, Shimizu C, Takahashi F, Tsuda H, Saji S, Hojo T, Sugano K, Takeuchi M, Fujii H, Fujiwara Y. Impact of recent parity on histopathological tumor features and breast cancer outcome in premenopausal Japanese women. Breast Cancer Res Treat. 2013;138:941–50.CrossRef
5.
Zurück zum Zitat Song N, Choi JY, Sung H, Jeon S, Chung S, Song M, Park SK, Han W, Lee JW, Kim MK, Yoo KY, Ahn SH, Noh DY, Kang D. Tumor subtype-specific associations of hormone-related reproductive factors on breast cancer survival. PLoS One. 2015;10:e0123994.CrossRef Song N, Choi JY, Sung H, Jeon S, Chung S, Song M, Park SK, Han W, Lee JW, Kim MK, Yoo KY, Ahn SH, Noh DY, Kang D. Tumor subtype-specific associations of hormone-related reproductive factors on breast cancer survival. PLoS One. 2015;10:e0123994.CrossRef
6.
Zurück zum Zitat Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Kaufman JS, Moorman PG, Cai J, Olshan AF, Porter PL, Brinton LA, Eley JW, Coates RJ. Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Res Treat. 2007;103:93–102.CrossRef Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Kaufman JS, Moorman PG, Cai J, Olshan AF, Porter PL, Brinton LA, Eley JW, Coates RJ. Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Res Treat. 2007;103:93–102.CrossRef
7.
Zurück zum Zitat Orgéas CC, Hall P, Rosenberg LU, Czene K. The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer. Breast Cancer Res. 2008;10:R107.CrossRef Orgéas CC, Hall P, Rosenberg LU, Czene K. The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer. Breast Cancer Res. 2008;10:R107.CrossRef
8.
Zurück zum Zitat Ewertz M, Gillanders S, Meyer L, Zedeler K. Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer. Int J Cancer. 1991;49:526–30.CrossRef Ewertz M, Gillanders S, Meyer L, Zedeler K. Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer. Int J Cancer. 1991;49:526–30.CrossRef
9.
Zurück zum Zitat Reeves GK, Patterson J, Vessey MP, Yeates D, Jones L. Hormonal and other factors in relation to survival among breast cancer patients. Int J Cancer. 2000;89:293–9.CrossRef Reeves GK, Patterson J, Vessey MP, Yeates D, Jones L. Hormonal and other factors in relation to survival among breast cancer patients. Int J Cancer. 2000;89:293–9.CrossRef
10.
Zurück zum Zitat Barnett GC, Shah M, Redman K, Easton DF, Ponder BA, Pharoah PD. Risk factors for the incidence of breast cancer: do they affect survival from the disease? J Clin Oncol. 2008;26:3310–6.CrossRef Barnett GC, Shah M, Redman K, Easton DF, Ponder BA, Pharoah PD. Risk factors for the incidence of breast cancer: do they affect survival from the disease? J Clin Oncol. 2008;26:3310–6.CrossRef
11.
Zurück zum Zitat Alsaker MD, Opdahl S, Asvold BO, Romundstad PR, Vatten LJ. The association of reproductive factors and breastfeeding with long term survival from breast cancer. Breast Cancer Res Treat. 2011;130:175–82.CrossRef Alsaker MD, Opdahl S, Asvold BO, Romundstad PR, Vatten LJ. The association of reproductive factors and breastfeeding with long term survival from breast cancer. Breast Cancer Res Treat. 2011;130:175–82.CrossRef
12.
Zurück zum Zitat Korzeniowski S. Dyba T (1994) Reproductive history and prognosis in patients with operable breast cancer. Cancer. 1994;74:1591–4.CrossRef Korzeniowski S. Dyba T (1994) Reproductive history and prognosis in patients with operable breast cancer. Cancer. 1994;74:1591–4.CrossRef
13.
Zurück zum Zitat Daling JR, Malone KE, Doody DR, Anderson BO, Porter PL. The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol Biomark Prev. 2002;11:235–41. Daling JR, Malone KE, Doody DR, Anderson BO, Porter PL. The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol Biomark Prev. 2002;11:235–41.
14.
Zurück zum Zitat Butt S, Borgquist S, Garne JP, Landberg G, Tengrup I, Olsson A, Manjer J. Parity in relation to survival following breast cancer. Eur J Surg Oncol. 2009;35:702–8.CrossRef Butt S, Borgquist S, Garne JP, Landberg G, Tengrup I, Olsson A, Manjer J. Parity in relation to survival following breast cancer. Eur J Surg Oncol. 2009;35:702–8.CrossRef
15.
Zurück zum Zitat Alsaker MD, Opdahl S, Romundstad PR, Vatten LJ. Association of time since last birth, age at first birth and parity with breast cancer survival among parous women: a register-based study from Norway. Int J Cancer. 2013;132:174–81.CrossRef Alsaker MD, Opdahl S, Romundstad PR, Vatten LJ. Association of time since last birth, age at first birth and parity with breast cancer survival among parous women: a register-based study from Norway. Int J Cancer. 2013;132:174–81.CrossRef
16.
Zurück zum Zitat Phillips KA, Milne RL, Friedlander ML, Jenkins MA, McCredie MR, Giles GG, Hopper JL. Prognosis of premenopausal breast cancer and childbirth prior to diagnosis. J Clin Oncol. 2004;22:699–705.CrossRef Phillips KA, Milne RL, Friedlander ML, Jenkins MA, McCredie MR, Giles GG, Hopper JL. Prognosis of premenopausal breast cancer and childbirth prior to diagnosis. J Clin Oncol. 2004;22:699–705.CrossRef
17.
Zurück zum Zitat Sun X, Nichols HB, Tse CK, Bell MB, Robinson WR, Sherman ME, Olshan AF, Troester MA. Association of parity and time since last birth with breast cancer prognosis by intrinsic subtype. Cancer Epidemiol Biomark Prev. 2016;25:60–7.CrossRef Sun X, Nichols HB, Tse CK, Bell MB, Robinson WR, Sherman ME, Olshan AF, Troester MA. Association of parity and time since last birth with breast cancer prognosis by intrinsic subtype. Cancer Epidemiol Biomark Prev. 2016;25:60–7.CrossRef
18.
Zurück zum Zitat Kawai M, Kakugawa Y, Nishino Y, Hamanaka Y, Ohuchi N, Minami Y. Reproductive factors and breast cancer risk in relation to hormone receptor and menopausal status in Japanese women. Cancer Sci. 2012;103:1861–70.CrossRef Kawai M, Kakugawa Y, Nishino Y, Hamanaka Y, Ohuchi N, Minami Y. Reproductive factors and breast cancer risk in relation to hormone receptor and menopausal status in Japanese women. Cancer Sci. 2012;103:1861–70.CrossRef
19.
Zurück zum Zitat Kawai M, Minami Y, Nishino Y, Fukamachi K, Ohuchi N, Kakugawa Y. Body mass index and survival after breast cancer diagnosis in Japanese women. BMC Cancer. 2012;12:149.CrossRef Kawai M, Minami Y, Nishino Y, Fukamachi K, Ohuchi N, Kakugawa Y. Body mass index and survival after breast cancer diagnosis in Japanese women. BMC Cancer. 2012;12:149.CrossRef
20.
Zurück zum Zitat Kakugawa Y, Kawai M, Nishino Y, Fukamachi K, Ishida T, Ohuchi N, Minami Y. Smoking and survival after breast cancer diagnosis in Japanese women: a prospective cohort study. Cancer Sci. 2015;106:1066–74.CrossRef Kakugawa Y, Kawai M, Nishino Y, Fukamachi K, Ishida T, Ohuchi N, Minami Y. Smoking and survival after breast cancer diagnosis in Japanese women: a prospective cohort study. Cancer Sci. 2015;106:1066–74.CrossRef
21.
Zurück zum Zitat Minami Y, Kanemura S, Oikawa T, Suzuki S, Hasegawa Y, Miura K, Nishino Y, Kakugawa Y, Fujiya T. Associations of cigarette smoking and alcohol drinking with stomach cancer survival: a prospective patient cohort study in Japan. Int J Cancer. 2018;143:1072–85.CrossRef Minami Y, Kanemura S, Oikawa T, Suzuki S, Hasegawa Y, Miura K, Nishino Y, Kakugawa Y, Fujiya T. Associations of cigarette smoking and alcohol drinking with stomach cancer survival: a prospective patient cohort study in Japan. Int J Cancer. 2018;143:1072–85.CrossRef
22.
Zurück zum Zitat Butt S, Borgquist S, Anagnostaki L, Landberg G, Manjer J. Parity and age at first childbirth in relation to the risk of different breast cancer subgroups. Int J Cancer. 2009;125:1926–34.CrossRef Butt S, Borgquist S, Anagnostaki L, Landberg G, Manjer J. Parity and age at first childbirth in relation to the risk of different breast cancer subgroups. Int J Cancer. 2009;125:1926–34.CrossRef
23.
Zurück zum Zitat Somasegar S, Li L, Thompson CL. No association of reproductive risk factors with breast cancer tumor grade. Eur J Cancer Prev. 2018;27:140–3.CrossRef Somasegar S, Li L, Thompson CL. No association of reproductive risk factors with breast cancer tumor grade. Eur J Cancer Prev. 2018;27:140–3.CrossRef
24.
Zurück zum Zitat Johansson AL, Andersson TM, Hsieh CC, Jirström K, Dickman P, Cnattingius S, Lambe M. Stage at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC). Breast Cancer Res Treat. 2013;139:183–92.CrossRef Johansson AL, Andersson TM, Hsieh CC, Jirström K, Dickman P, Cnattingius S, Lambe M. Stage at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC). Breast Cancer Res Treat. 2013;139:183–92.CrossRef
25.
Zurück zum Zitat Wang Z, Dang S, Xing Y, Li Q, Yan H. Correlation of body mass index levels with menarche in adolescent girls in Shaanxi, China: a cross sectional study. BMC Womens Health. 2016;16:61.CrossRef Wang Z, Dang S, Xing Y, Li Q, Yan H. Correlation of body mass index levels with menarche in adolescent girls in Shaanxi, China: a cross sectional study. BMC Womens Health. 2016;16:61.CrossRef
26.
Zurück zum Zitat Dossus L, Kvaskoff M, Bijon A, Fervers B, Boutron-Ruault MC, Mesrine S, Clavel-Chapelon F. Determinants of age at menarche and time to menstrual cycle regularity in the French E3N cohort. Ann Epidemiol. 2012;22:723–30.CrossRef Dossus L, Kvaskoff M, Bijon A, Fervers B, Boutron-Ruault MC, Mesrine S, Clavel-Chapelon F. Determinants of age at menarche and time to menstrual cycle regularity in the French E3N cohort. Ann Epidemiol. 2012;22:723–30.CrossRef
27.
Zurück zum Zitat Braithwaite D, Moore DH, Lustig RH, Epel ES, Ong KK, Rehkopf DH, Wang MC, Miller SM, Hiatt RA. Socioeconomic status in relation to early menarche among black and white girls. Cancer Causes Control. 2009;20:713–20.CrossRef Braithwaite D, Moore DH, Lustig RH, Epel ES, Ong KK, Rehkopf DH, Wang MC, Miller SM, Hiatt RA. Socioeconomic status in relation to early menarche among black and white girls. Cancer Causes Control. 2009;20:713–20.CrossRef
28.
Zurück zum Zitat Al-Sahab B, Ardern CI, Hamadeh MJ, Tamim H. Age at menarche in Canada: results from the National Longitudinal Survey of Children & Youth. BMC Public Health. 2010;10:736.CrossRef Al-Sahab B, Ardern CI, Hamadeh MJ, Tamim H. Age at menarche in Canada: results from the National Longitudinal Survey of Children & Youth. BMC Public Health. 2010;10:736.CrossRef
29.
Zurück zum Zitat Lee MH, Kim SH, Oh M, Lee KW, Park MJ. Age at menarche in Korean adolescents: trends and influencing factors. Reprod Health. 2016;13:121.CrossRef Lee MH, Kim SH, Oh M, Lee KW, Park MJ. Age at menarche in Korean adolescents: trends and influencing factors. Reprod Health. 2016;13:121.CrossRef
30.
Zurück zum Zitat Kroman N, Wohlfahrt J, Andersen KW, Mouridsen HT, Westergaard T, Melbye M. Parity, age at first childbirth and the prognosis of primary breast cancer. Br J Cancer. 1998;78:1529–33.CrossRef Kroman N, Wohlfahrt J, Andersen KW, Mouridsen HT, Westergaard T, Melbye M. Parity, age at first childbirth and the prognosis of primary breast cancer. Br J Cancer. 1998;78:1529–33.CrossRef
31.
Zurück zum Zitat Warren Andersen S, Newcomb PA, Hampton JM, Titus-Ernstoff L, Egan KM, Trentham-Dietz A. Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis. Breast Cancer Res Treat. 2011;130:975–80.CrossRef Warren Andersen S, Newcomb PA, Hampton JM, Titus-Ernstoff L, Egan KM, Trentham-Dietz A. Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis. Breast Cancer Res Treat. 2011;130:975–80.CrossRef
32.
Zurück zum Zitat Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, McTiernan A. Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations. Cancer Epidemiol Biomark Prev. 2004;13:1296–301. Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, McTiernan A. Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations. Cancer Epidemiol Biomark Prev. 2004;13:1296–301.
33.
Zurück zum Zitat Hankinson SE, Colditz GA, Hunter DJ, Manson JE, Willett WC, Stampfer MJ, Longcope C, Speizer FE. Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses’ Health Study (United States). Cancer Causes Control. 1995;6:217–24.CrossRef Hankinson SE, Colditz GA, Hunter DJ, Manson JE, Willett WC, Stampfer MJ, Longcope C, Speizer FE. Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses’ Health Study (United States). Cancer Causes Control. 1995;6:217–24.CrossRef
34.
Zurück zum Zitat Duggan C, Stanczyk F, Campbell K, Neuhouser ML, Baumgartner RN, Baumgartner KB, Bernstein L, Ballard R, McTiernan A. Associations of sex steroid hormones with mortality in women with breast cancer. Breast Cancer Res Treat. 2016;155:559–67.CrossRef Duggan C, Stanczyk F, Campbell K, Neuhouser ML, Baumgartner RN, Baumgartner KB, Bernstein L, Ballard R, McTiernan A. Associations of sex steroid hormones with mortality in women with breast cancer. Breast Cancer Res Treat. 2016;155:559–67.CrossRef
35.
Zurück zum Zitat Grundy E. Women’s fertility and mortality in late mid life: a comparison of three contemporary populations. Am J Hum Biol. 2009;21:541–7.CrossRef Grundy E. Women’s fertility and mortality in late mid life: a comparison of three contemporary populations. Am J Hum Biol. 2009;21:541–7.CrossRef
36.
Zurück zum Zitat Choi JI, Han KD, Kim SJ, Kim MJ, Shin JE, Lee HN. Relationship between delivery history and health-related quality of life in menopausal South Korean women: the Korea National Health and Nutrition Examination Surveys. Maturitas. 2016;92:24–9.CrossRef Choi JI, Han KD, Kim SJ, Kim MJ, Shin JE, Lee HN. Relationship between delivery history and health-related quality of life in menopausal South Korean women: the Korea National Health and Nutrition Examination Surveys. Maturitas. 2016;92:24–9.CrossRef
37.
Zurück zum Zitat Rosenberg L, Thalib L, Adami HO, Hall P. Childbirth and breast cancer prognosis. Int J Cancer. 2004;111:772–6.CrossRef Rosenberg L, Thalib L, Adami HO, Hall P. Childbirth and breast cancer prognosis. Int J Cancer. 2004;111:772–6.CrossRef
38.
Zurück zum Zitat Albrektsen G, Heuch I, Kvåle G. The short-term and long-term effect of a pregnancy on breast cancer risk: a prospective study of 802,457 parous Norwegian women. Br J Cancer. 1995;72:480–4.CrossRef Albrektsen G, Heuch I, Kvåle G. The short-term and long-term effect of a pregnancy on breast cancer risk: a prospective study of 802,457 parous Norwegian women. Br J Cancer. 1995;72:480–4.CrossRef
39.
Zurück zum Zitat Adami HO, Persson I, Ekbom A, Wolk A, Pontén J, Trichopoulos D. The aetiology and pathogenesis of human breast cancer. Mutat Res. 1995;333:29–35.CrossRef Adami HO, Persson I, Ekbom A, Wolk A, Pontén J, Trichopoulos D. The aetiology and pathogenesis of human breast cancer. Mutat Res. 1995;333:29–35.CrossRef
40.
Zurück zum Zitat Gupta PB, Kuperwasser C. Contributions of estrogen to ER–negative breast tumor growth. J Steroid Biochem Mol Biol. 2006;102:71–8.CrossRef Gupta PB, Kuperwasser C. Contributions of estrogen to ER–negative breast tumor growth. J Steroid Biochem Mol Biol. 2006;102:71–8.CrossRef
Metadaten
Titel
Reproductive history and breast cancer survival: a prospective patient cohort study in Japan
verfasst von
Yuko Minami
Yoshikazu Nishino
Masaaki Kawai
Hiroshi Tada
Seiki Kanemura
Minoru Miyashita
Takanori Ishida
Yoichiro Kakugawa
Publikationsdatum
15.04.2019
Verlag
Springer Japan
Erschienen in
Breast Cancer / Ausgabe 6/2019
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-019-00972-5

Weitere Artikel der Ausgabe 6/2019

Breast Cancer 6/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.